(19)
(11) EP 1 534 317 A2

(12)

(88) Date of publication A3:
17.03.2005

(43) Date of publication:
01.06.2005 Bulletin 2005/22

(21) Application number: 02756157.0

(22) Date of filing: 10.06.2002
(51) International Patent Classification (IPC)7A61K 38/16, A61K 48/00, A61K 39/395, C07K 14/435, C07K 16/32, C07H 21/04
(86) International application number:
PCT/US2002/018478
(87) International publication number:
WO 2002/100343 (19.12.2002 Gazette 2002/51)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 08.06.2001 US 296970 P

(71) Applicant: Mandalmed, Inc.
San Francisco, CA 94132 (US)

(72) Inventors:
  • JARVIS, Gary, A.,MandalMed, Inc.
    San Francisco, CA 94132 (US)
  • JOHN, Constance, M.,MandalMed, Inc.
    San Francisco, CA 94132 (US)
  • LEFFLER, Hakon,MandalMed, Inc.
    San Francisco, CA 94132 (US)

(74) Representative: Tombling, Adrian George et al
Withers & Rogers LLPGoldings House,2 Hays Lane
London SE1 2HW
London SE1 2HW (GB)

   


(54) N-TERMINALLY TRUNCATED GALECTIN-3 AND ANTIBODIES FOR TREATING CANCER